Safety and efficacy of valsartan versus enalapril in heart failure patients.

Research output: Contribution to journalArticle


  • Ronnie Willenheimer
  • Claes Helmers
  • Emil Pantev
  • Erik Rydberg
  • Per Löfdahl
  • Allan Gordon
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cardiac and Cardiovascular Systems


  • Aged, Double-Blind Method, Enalapril: adverse effects, Enalapril: therapeutic use, Female, Heart Failure, Comparative Study, Angiotensin-Converting Enzyme Inhibitors: therapeutic use, 80 and over, Analysis of Variance, Angiotensin-Converting Enzyme Inhibitors: adverse effects, Congestive: drug therapy, Human, Male, Middle Age, Receptors, Angiotensin: antagonists & inhibitors, Support, Non-U.S. Gov't, Tetrazoles: adverse effects, Tetrazoles: therapeutic use, Treatment Outcome, Valine: adverse effects, Valine: analogs & derivatives, Valine: therapeutic use
Original languageEnglish
Pages (from-to)261-270
JournalInternational Journal of Cardiology
Issue number2-3
Publication statusPublished - 2002
Publication categoryResearch

Bibliographic note

The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Internal Medicine (013242500), Cardiology (013230026), Emergency medicine/Medicine/Surgery (013240200)